Leveraging Data to Scale Drug Development Globally - with Damion Nero of Takeda 72429

Today’s guest is Damion Nero, Head of Data Science at Takeda Pharmaceuticals. With over 15 years...

Today’s guest is Damion Nero, Head of Data Science at Takeda Pharmaceuticals. With over 15 years of experience applying AI, machine learning, and real-world data to drug development and precision medicine, Damion s Emerj Managing Editor Matthew DeMello to explore the evolving role of AI in drug development and supply chain management. He breaks down how AI is currently streamlining istrative and regulatory tasks, improving efficiency across clinical trials, and saving valuable time for healthcare professionals. Damion also discusses why broader, transformative supply chain efficiencies are still on the horizon, as AI continues to evolve and scale in the pharmaceutical industry. This episode is sponsored by Arkestro. Learn more about Arkestro’s Advisory Council event here. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.

Building Better PCB Layouts with AI Driven Optimization - with Alain-Sam Cohen of InstaDeep 5 días 23:17 Evolving Expectations in Fraud and Risk Response from Dispute to Detection - with Naveen Kumar of Walmart 2 días 16:13 Driving AI in Fraud and AML Compliance for Financial Services - with Nick Lewis of Standard Chartered Bank 1 día 20:57 The AI Minded Path to Scalable and Responsible Innovation Across the Enterprise - with James Raybould of Turing Intellig Hoy días 31:17 Rethinking Customer Experiences with AI-Driven Conversations - with Alan Ranger of Cognigy 6 días 29:04 Ver más en APP Comentarios del episodio 33v38